113 related articles for article (PubMed ID: 20674353)
1. Development of methotrexate proline prodrug to overcome resistance by MDA-MB-231 cells.
Wu Z; Shah A; Patel N; Yuan X
Bioorg Med Chem Lett; 2010 Sep; 20(17):5108-12. PubMed ID: 20674353
[TBL] [Abstract][Full Text] [Related]
2. Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide.
Lindgren M; Rosenthal-Aizman K; Saar K; Eiríksdóttir E; Jiang Y; Sassian M; Ostlund P; Hällbrink M; Langel U
Biochem Pharmacol; 2006 Feb; 71(4):416-25. PubMed ID: 16376307
[TBL] [Abstract][Full Text] [Related]
3. Prolidase, a potential enzyme target for melanoma: design of proline-containing dipeptide-like prodrugs.
Mittal S; Song X; Vig BS; Landowski CP; Kim I; Hilfinger JM; Amidon GL
Mol Pharm; 2005; 2(1):37-46. PubMed ID: 15804176
[TBL] [Abstract][Full Text] [Related]
4. Proline analogue of melphalan as a prodrug susceptible to the action of prolidase in breast cancer MDA-MB 231 cells.
Chrzanowski K; Bielawska A; Pałka J
Farmaco; 2003 Nov; 58(11):1113-9. PubMed ID: 14572862
[TBL] [Abstract][Full Text] [Related]
5. Sequence-dependent administration of 5-fluorouracil maintains methotrexate antineoplastic activity in human estrogen-negative breast cancer and protects against methotrexate cytotoxicity in human bone marrow.
Das JR; Fryar-Tita EB; Zhou Y; Green S; Southerland WM; Bowen D
Anticancer Res; 2007; 27(6B):3791-9. PubMed ID: 18225534
[TBL] [Abstract][Full Text] [Related]
6. Implications for improved high-dose methotrexate therapeutic effects in cultured human breast cancer and bone marrow cells.
Bowen D; Southerland WM; Johnson DH; Hawkins M; Hughes DE
Cancer Detect Prev; 2000; 24(5):452-8. PubMed ID: 11129987
[TBL] [Abstract][Full Text] [Related]
7. Decreased cytotoxicity and increased antimitotic activity of a proline analogue of chlorambucil as a prodrug susceptible to the action of fibroblast's prolidase.
Bielawska A; Chrzanowski K; Bielawski K; Pałka J
Pharmazie; 2001 Apr; 56(4):290-4. PubMed ID: 11338665
[TBL] [Abstract][Full Text] [Related]
8. 5-Fluorouracil simultaneously maintains methotrexate antineoplastic activity in human breast cancer and protects against methotrexate cytotoxicity in human bone marrow.
Bowen D; Johnson DH; Southerland WM; Hughes DE; Hawkins M
Anticancer Res; 1999; 19(2A):985-8. PubMed ID: 10368642
[TBL] [Abstract][Full Text] [Related]
9. Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone.
Weigand M; Hartung G; Roboz J; Sieger S; Wolf M; Sinn H; Schrenk HH; Wiessler M; Frei E
Anticancer Drug Des; 2001; 16(4-5):227-37. PubMed ID: 12049481
[TBL] [Abstract][Full Text] [Related]
10. Proteomic identification of differentially expressed proteins associated with the multiple drug resistance in methotrexate-resistant human breast cancer cells.
Chen S; Cai J; Zhang W; Zheng X; Hu S; Lu J; Xing J; Dong Y
Int J Oncol; 2014 Jul; 45(1):448-58. PubMed ID: 24736981
[TBL] [Abstract][Full Text] [Related]
11. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells.
Chen G; Wright JE; Rosowsky A
Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904
[TBL] [Abstract][Full Text] [Related]
12. A cell surface tethered enzyme improves efficiency in gene-directed enzyme prodrug therapy.
Marais R; Spooner RA; Stribbling SM; Light Y; Martin J; Springer CJ
Nat Biotechnol; 1997 Dec; 15(13):1373-7. PubMed ID: 9415889
[TBL] [Abstract][Full Text] [Related]
13. Differential subcellular distribution of mitoxantrone in relation to chemosensitization in two human breast cancer cell lines.
Vibet S; Mahéo K; Goré J; Dubois P; Bougnoux P; Chourpa I
Drug Metab Dispos; 2007 May; 35(5):822-8. PubMed ID: 17296624
[TBL] [Abstract][Full Text] [Related]
14. Suppression of growth and cancer-induced angiogenesis of aggressive human breast cancer cells (MDA-MB-231) on the chorioallantoic membrane of developing chicken embryos by E-peptide of pro-IGF-I.
Chen MJ; Chiou PP; Lin P; Lin CM; Siri S; Peck K; Chen TT
J Cell Biochem; 2007 Aug; 101(5):1316-27. PubMed ID: 17286280
[TBL] [Abstract][Full Text] [Related]
15. [Primary study on establishment of namalwa 12/MTX resistant cell strain and its mechanism].
Chen J; Gu LJ; Ying DM; Shen M; Wu HJ
Ai Zheng; 2002 Dec; 21(12):1335-40. PubMed ID: 12520743
[TBL] [Abstract][Full Text] [Related]
16. Sensitization of human erythroleukemia K562 cells resistant to methotrexate by inhibiting IMPDH.
Peñuelas S; Noé V; Morales R; Ciudad CJ
Med Sci Monit; 2005 Jan; 11(1):BR6-12. PubMed ID: 15614187
[TBL] [Abstract][Full Text] [Related]
17. The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest.
Kim JB; Yu JH; Ko E; Lee KW; Song AK; Park SY; Shin I; Han W; Noh DY
Phytomedicine; 2010 May; 17(6):436-40. PubMed ID: 19800775
[TBL] [Abstract][Full Text] [Related]
18. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.
Landis-Piwowar KR; Huo C; Chen D; Milacic V; Shi G; Chan TH; Dou QP
Cancer Res; 2007 May; 67(9):4303-10. PubMed ID: 17483343
[TBL] [Abstract][Full Text] [Related]
19. Growth factors and chemotherapeutic modulation of breast cancer cells.
Ciftci K; Su J; Trovitch PB
J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
[TBL] [Abstract][Full Text] [Related]
20. Sequence- and time-dependent antagonism between raloxifene and methotrexate in human breast cancer cells.
De Soto JA; Bowen D; Davis JH; Southerland WM; Hawkins M
Anticancer Res; 2002; 22(2A):1007-9. PubMed ID: 12014617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
